Enochian Biosciences (ENOB) Financials

$1.56

$0.86 (122.86%)

As on 11-Aug-2023 09:30EDT

Market cap

$31 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	21.17	22.83	23.40	11.92	10.99	8.17
Operating Profit (EBIT)	-114.42	-22.83	-23.40	-11.92	-10.99	-8.17
Other Income	-0.41	--	--	0.61	-7.03	-0.95
Profit before Tax	-192.50	-113.43	-26.85	-11.42	-18.02	-9.26
Provision for Tax	387,234.29	--	-0.13	-0.56	7.10	-0.11
Profit after Tax (Net Income)	-387,426.79	-113.43	-26.72	-10.85	-25.12	-9.15
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-12.03	--	-26.72	-11.42	-18.02	-6.31

Liabilities ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Shareholder's Funds	66.13	72.62	174.66	166.27	173.10	155.90
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.83	5.56	13.06	10.50	5.67	22.89
Current Liabilities	11.77	6.45	1.89	1.33	1.11	0.87
Total Liabilities	90.50	84.63	189.61	178.10	179.88	179.66

Assets ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Non-Current Assets	74.80	75.07	168.71	169.16	167.38	163.90
Current Assets	3.93	9.57	20.90	8.94	12.49	15.76
Total Assets	90.50	--	189.61	178.10	179.88	179.66
Total Debt*	7.04	--	7.31	7.58	--	--
Net Current Assets	-7.85	3.11	19.01	7.61	11.38	14.89

Cashflow ($ Mln)	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Cash From Operating Activities	--	-15.73	-20.61	-10.46	-8.51	-4.34
Cash Flow from Investing Activities	--	--	-0.05	-0.18	-0.72	-0.58
Cash from Financing Activities	--	4.25	32.60	7.20	6.02	16.71
Net Cash Inflow / Outflow	--	--	--	-3.59	-3.32	11.66

Financials Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Adjusted EPS ($)	-6,918.43	-2.14	-0.57	-0.24	-0.66	-0.42
Cash EPS ($)	--	-2.14	-0.56	-0.23	-0.66	-0.29
Adjusted Book Value ($)	--	1.37	3.72	3.61	4.56	7.09
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.30	-0.44	-0.23	-0.22	-0.20
Free Cash Flow per Share ($)	--	-0.30	-0.44	-0.23	-0.24	-0.20

Profitability Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
ROCE (%)	--	-89.11	-15.02	-6.26	-15.27	-11.47
ROE (%)	-567,853.84	-91.74	-15.68	-6.40	-15.27	-11.63
ROA (%)	-278,607.70	-82.73	-14.54	-6.06	-13.97	-9.94
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	93,681,140.44	--	--	-1,774.59	357.46	962.38
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-219.06	--	-96.26	-8.50	-34.53	-208.23
Net Profit Growth (%)	-904,983.19	-324.47	-146.19	56.78	-174.44	-282.47
EPS Growth (%)	-808,409.18	-2.76	-1.41	0.64	-0.59	-1.09
Book Value Growth (%)	-61.19	--	--	--	--	--

Valuation Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Price / Earnings	--	-0.90	-8.74	-17.84	-6.81	-7.98
Price / Book Value	0.45	1.41	1.34	1.16	0.99	0.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.73	-0.82	-9.58	-16.37	-14.64	-10.91
Close Price ($)	0.92	1.93	4.97	4.21	4.50	3.32
High Price ($)	8.88	13.78	12.99	13.43	9.50	7.10
Low Price ($)	0.86	1.88	2.60	1.95	3.32	1.60
Market Cap ($ Cr)	30.95	--	--	--	--	--

Solvency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debt to Equity	--	--	0.04	0.05	--	--
Short term debt to equity ratio	0.09	--	0.00	0.00	--	--
Current Ratio	0.33	1.48	11.08	6.70	11.25	18.04
Quick Ratio	0.33	--	--	--	11.25	18.04
Interest Coverage	-349.34	--	-61.65	-114.34	-255,582.14	-57.02

Operating Efficiency Ratios	TTM	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16	Jun-15	Jun-14	Jun-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.